Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy.

Authors :: Hashmi H
Bachmeier C
Chavez JC
Song J
Hussaini M
Krivenko G
Nishihori T
Kotani H
Davila ML
Locke FL
Jain MD
Source :: British journal of haematology [Br J Haematol] 2019 Oct; Vol. 187 (2), pp. e35-e38. Date of Electronic Publication: 2019 Aug 13.
Publication Year :: 2019

Subjects :: Humans
Lymphohistiocytosis, Hemophagocytic blood
Lymphohistiocytosis, Hemophagocytic diagnosis
Male
Middle Aged
Antigens, CD19
Immunotherapy, Adoptive
Lymphohistiocytosis, Hemophagocytic therapy
Receptors, Chimeric Antigen

Full Text Access

Tools